Table 2 Mean (standard deviation) and repeated-measure ANOVA of clinical scores during pre- and post-test interventions
Groups | ||||||
|---|---|---|---|---|---|---|
| Â | Experimental | Waitlist-Control | Â | Â | ||
Baseline | Post-Test | Baseline | Post-Test | |||
M (SD) | M (SD) | M (SD) | M (SD) | F | η2 | |
PHQ | 15.85(3.81) | 8.81(2.59) | 15.80(4.12) | 16.54(3.97) | 94.44*** | .62 |
SHAI | 29.81(6.83) | 15.26(1.94) | 29.49(7.17) | 32.29(6.04) | 201.92*** | .77 |
EBS | 3.72(0.90) | 2.36(0.55) | 3.79(0.75) | 3.93(0.78) | 103.64*** | .64 |
PDS | 4.57(0.73) | 2.67(0.73) | 4.10(0.86) | 4.04(0.78) | 129.09*** | .68 |
RDS | 4.60(0.72) | 2.71(0.689) | 4.12(.88) | 3.85(0.76) | 118.63*** | .67 |
IDS | 3.56(1.12) | 2.31(0.62) | 3.75(.93) | 3.61(0.87) | 29.71*** | .31 |
DDS | 16.46(2.71) | 10.05(2.22) | 15.77(2.99) | 15.45(2.93) | 222.71*** | .79 |
PBNA | 8.78(2.34) | 28.19(1.41) | 9.51(2.39) | 9.77(1.99) | 56.33*** | .49 |
ADPB | 7.48(2.19) | 10.93(1.33) | 7.49(2.06) | 7.29(1.78) | 43.65*** | .42 |
CRNA | 3.96(1.51) | 5.89(0.32) | 3.77(1.301) | 3.37(1.26) | 61.65*** | .51 |
GMAS | 20.22(4.73) | 28.19(3.04) | 20.77(4.61) | 20.86(3.80) | 67.58*** | .57 |
SATS | 67.65(13.20) | 49.51(11.76) | 69.05(14.38) | 69.71(11.45) | 41.37*** | .41 |
IMPS | 68.89(12.28) | 47.04(11.29) | 73.43(13.66) | 71.71(9.85) | 44.13*** | .43 |
WORS | 64.69(15.89) | 45.93(13.76) | 68.19(17.79) | 72(14.36) | 40.86*** | .41 |
DQLS | 67.35(10.41) | 12.85(9.99) | 70.20(12.79) | 70.86(9.85) | 83.35*** | .58 |
WALS | 389.27(323.7) | 1103.6(260.90) | 550.3(505.5) | 550.3(505.5) | 134.70*** | .70 |
MPAS | 171.1(286.20) | 456.2(453.80) | 84.0(240.50) | 96.0(271.10) | 17.61*** | .28 |
VPAS | 41.48(149.45) | 528.88(598.18) | 96.0(395.60) | 96.0(395.60) | 29.74*** | .33 |
IPAQ | 601.8(512.84) | 20.88(925.4) | 735.6(861.8) | 747.97(889.88) | 164.25*** | .74 |